Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development

Journal of Immunological Methods

Volumn 416, Issue , 2015, Pages 105-123

  Stephenson, Kathryn E ^a   Neubauer, George H ^a   Reimer, Ulf ^b   Pawlowski, Nikolaus ^b,e   Knaute, Tobias ^b   Zerweck, Johannes ^b   Korber, Bette T ^c   Barouch, Dan H ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JPT Peptide Technologies GmbH   (Germany)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e Global Biologics Research   (Germany)

Author keywords

Antibody; Diversity; HIV; Peptide microarray; Vaccine

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; PROTEOME; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; GUINEA PIG; HUMAN; MEASUREMENT ACCURACY; MICROARRAY ANALYSIS; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SEQUENCE DATABASE; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY;

CAVIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA;

AIDS VACCINES; ANIMALS; EPITOPES; GUINEA PIGS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MACACA MULATTA; PEPTIDES;

EID: 84961291532     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.11.006     Document Type: Article

References (41)

1. Barouch D.H., Korber B. HIV-1 vaccine development after Step. Annu. Rev. Med. 2009, 61:2.1.
2. Barouch D.H., Liu J., Li H., Maxfield L.F., Abbink P., Lynch D.M., Iampietro M.J., SanMiguel A., Seaman M.S., Ferrari G., Forthal D.N., Ourmanov I., Hirsch V.M., Carville A., Mansfield K.G., Stablein D., Pau M.G., Schuitemaker H., Sadoff J.C., Billings E.A., Rao M., Robb M.L., Kim J.H., Marovich M.A., Goudsmit J., Michael N.L. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 2012, 482:89.
3. Barouch D.H., O'Brien K.L., Simmons N.L., King S.L., Abbink P., Maxfield L.F., Sun Y.H., La Porte A., Riggs A.M., Lynch D.M., Clark S.L., Backus K., Perry J.R., Seaman M.S., Carville A., Mansfield K.G., Szinger J.J., Fischer W., Muldoon M., Korber B. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat. Med. 2010, 16:319.
4. Barouch D.H., Stephenson K.E., Borducchi E.N., Smith K., Stanley K., McNally A.G., Liu J., Abbink P., Maxfield L.F., Seaman M.S., Dugast A.S., Alter G., Ferguson M., Li W., Earl P.L., Moss B., Giorgi E.E., Szinger J.J., Eller L.A., Billings E.A., Rao M., Tovanabutra S., Sanders-Buell E., Weijtens M., Pau M.G., Schuitemaker H., Robb M.L., Kim J.H., Korber B.T., Michael N.L. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell 2013, 155:531.
5. Cerecedo I., Zamora J., Shreffler W.G., Lin J., Bardina L., Dieguez M.C., Wang J., Muriel A., de la Hoz B., Sampson H.A. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J. Allergy Clin. Immunol. 2008, 122:589.
6. Fischer W., Perkins S., Theiler J., Bhattacharya T., Yusim K., Funkhouser R., Kuiken C., Haynes B., Letvin N.L., Walker B.D., Hahn B.H., Korber B.T. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 2007, 13:100.
7. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296:2354.
8. Gaseitsiwe S., Valentini D., Mahdavifar S., Magalhaes I., Hoft D.F., Zerweck J., Schutkowski M., Andersson J., Reilly M., Maeurer M.J. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. PLoS One 2008, 3:e3840.
9. Gottardo R., Bailer R.T., Korber B.T., Gnanakaran S., Phillips J., Shen X., Tomaras G.D., Turk E., Imholte G., Eckler L., Wenschuh H., Zerweck J., Greene K., Gao H., Berman P.W., Francis D., Sinangil F., Lee C., Nitayaphan S., Rerks-Ngarm S., Kaewkungwal J., Pitisuttithum P., Tartaglia J., Robb M.L., Michael N.L., Kim J.H., Zolla-Pazner S., Haynes B.F., Mascola J.R., Self S., Gilbert P., Montefiori D.C. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PLoS One 2013, 8:e75665.
10. Goudsmit J. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts. AIDS 1988, 2(Suppl. 1):S41.
11. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., Evans D.T., Montefiore D.C., Karnasuta C., Sutthent R., Liao H.X., DeVico A.L., Lewis G.K., Williams C., Pinte R.A., Fong Y., Janes H., DeCamp A., Huang Y., Rao M., Billings E., Karasavvas N., Robb M.L., Ngauy V., de Souza M.S., Paris R., Ferrari G., Bailer R.T., Soderberg K.A., Andrews C., Berman P.W., Frahm N., De Rosa S.C., Alpert M.D., Yates N.L., Shen X., Koup R.A., Pitisuttithum P., Kaewkungwal J., Nitayaphan S., Rerks-Ngarm S., Michael N.L., Kim J.H. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012, 366:1275.
12. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global and regional distributions of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13.
13. Imholte G.C., Sauteraud R., Korber B., Bailer R.T., Turk E.T., Shen X., Tomaras G.D., Mascola J.R., Koup R.A., Montefiori D.C., Gottardo R. A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling. J. Immunol. Methods 2013, 395:1.
14. Karasavvas N., Billings E., Rao M., Williams C., Zolla-Pazner S., Bailer R.T., Koup R.A., Madnote S., Arworn D., Shen X., Tomaras G.D., Currier J.R., Jiang M., Magaret C., Andrews C., Gottardo R., Gilbert P., Cardozo T.J., Rerks-Ngarm S., Nitayaphan S., Pitisuttithum P., Kaewkungwal J., Paris R., Greene K., Gao H., Gurunathan S., Tartaglia J., Sinangil F., Korber B.T., Montefiori D.C., Mascola J.R., Robb M.L., Haynes B.F., Ngauy V., Michael N.L., Kim J.H., de Souza M.S. The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. AIDS Res. Hum. Retroviruses 2012, 28:1444. Collaboration, M.T.
15. Korber B.T., Foley B., Gaschen B., Kuiken C. Epidemiological and immunological implications of the global variability of HIV-1. Retroviral Immune Response and Restoration 2001, 1. Humana Press, Totowa, New Jersey.
16. Korber B.T., Letvin N.L., Haynes B.F. T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J. Virol. 2009, 83:8300.
17. HIV Sequence Compendium. Published by Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 09-03280 2009, www.hiv.lanl.gov.
18. Lewis G.K. Role of Fc-mediated antibody function in protective immunity against HIV-1. Immunology 2014, 142:46.
19. Lorenz P., Kreutzer M., Zerweck J., Schutkowski M., Thiesen H.J. Probing the epitope signatures of IgG antibodies in human serum from patients with autoimmune disease. Methods Mol. Biol. 2009, 524:247.
20. Masch A., Zerweck J., Reimer U., Wenschuh H., Schutkowski M. Antibody signatures defined by high-content peptide microarray analysis. Methods Mol. Biol. 2010, 669:161.
21. McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., Haynes B.F. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 2010, 10:11.
22. Nahtman T., Jernberg A., Mahdavifar S., Zerweck J., Schutkowski M., Maeurer M., Reilly M. Validation of peptide epitope microarray experiments and extraction of quality data. J. Immunol. Methods 2007, 328:1.
23. Ndung'u T., Weiss R.A. On HIV diversity. AIDS 2012, 26:1255.
24. Nkolola J.P., Bricault C.A., Cheung A., Shields J., Perry J., Kovacs J.M., Giorgi E., van Winsen M., Apetri A., Brinkman-van der Linden E.C., Chen B., Korber B., Seaman M.S., Barouch D.H. Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer. J. Virol. 2014, 88:9538.
25. Nkolola J.P., Peng H., Settembre E.C., Freeman M., Grandpre L.E., Devoy C., Lynch D.M., La Porte A., Simmons N.L., Bradley R., Montefiori D.C., Seaman M.S., Chen B., Barouch D.H. Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs. J. Virol. 2010, 84:3270.
26. Picker L.J., Hansen S.G., Lifson J.D. New paradigms for HIV/AIDS vaccine development. Annu. Rev. Med. 2012, 63:95.
27. Renard B.Y., Löwer M., Kühne Y., Reimer U., Rothermel A., Türeci O., Castle J.C., Sahin U. rapmad: robust analysis of peptide microarray data. BMC Bioinformatics 2011, 12:324.
28. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., Gao F., Hahn B.H., Kalish M.L., Kuiken C., Learn G.H., Leitner T., McCutchan F., Osmanov S., Peeters M., Pieniazek D., Salminen M., Sharp P.M., Wolinsky S., Korber B. HIV-1 nomenclature proposal. Science 2000, 288:55.
29. Stephenson K.E., Barouch D.H. A global approach to HIV-1 vaccine development. Immunol. Rev. 2013, 254:295.
30. Stephenson K.E., SanMiguel A., Simmons N.L., Smith K., Lewis M.G., Szinger J.J., Korber B., Barouch D.H. Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys. J. Virol. 2012, 86:11434.
31. Taylor B.S., Sobieszczyk M.E., McCutchan F.E., Hammer S.M. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 2008, 358:1590.
32. Theoretical Biology and Biophysics, L.A.N.L. HIV Molecular Immunology: Maps of Ab Epitope Locations Plotted by Protein 2010, http://www.hiv.lanl.gov/content/immunology.
33. Theoretical Biology and Biophysics, L.A.N.L. HIV Molecular Immunology: Antibody Epitope Summary 2014, http://www.hiv.lanl.gov/content/immunology.
34. Thurmond J., Yoon H., Juiken C., Yusim K., Perkins S., Theiler J., et al. Web-based design and evaluation of T-cell vaccine candidates. Bioinformatics 2008, 24:1639.
35. Tomaras G.D., Binley J.M., Gray E.S., Crooks E.T., Osawa K., Moore P.L., Tumba N., Tong T., Shen X., Yates N.L., Decker J., Wibmer C.K., Gao F., Alam S.M., Easterbrook P., Abdool Karim S., Kamanga G., Crump J.A., Cohen M., Shaw G.M., Mascola J.R., Haynes B.F., Montefiori D.C., Morris L. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J. Virol. 2011, 85:11502.
36. Tomaras G.D., Haynes B.F. HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr. Opin. HIV AIDS 2009, 4:373.
37. Tomaras G.D., Yates N.L., Liu P., Qin L., Fouda G.G., Chavez L.L., Decamp A.C., Parks R.J., Ashley V.C., Lucas J.T., Cohen M., Eron J., Hicks C.B., Liao H.X., Self S.G., Landucci G., Forthal D.N., Weinhold K.J., Keele B.F., Hahn B.H., Greenberg M.L., Morris L., Karim S.S., Blattner W.A., Montefiori D.C., Shaw G.M., Perelson A.S., Haynes B.F. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 2008, 82:12449.
38. Trkola A., Kuster H., Leemann C., Oxenius A., Fagard C., Furrer H., Battegay M., Vernazza P., Bernasconi E., Weber R., Hirschel B., Bonhoeffer S., Gunthard H.F., Swiss H.I.V.C.S. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 2004, 104:1784.
39. Walker B.D., Ahmed R., Plotkin S. Use both arms to beat HIV. Nat. Med. 2011, 17:1194.
40. Weber J.N., Clapham P.R., Weiss R.A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R.S., Pinching A.J. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet 1987, 1:119.
41. Zhang M., Foley B., Schultz A.K., Macke J.P., Bulla I., Stanke M., Morgenstern B., Korber B., Leitner T. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 2010, 7:25.